These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 24374223)

  • 21. Effect of processing history on the surface interfacial properties of budesonide in carrier-based dry-powder inhalers.
    Shur J; Pitchayajittipong C; Rogueda P; Price R
    Ther Deliv; 2013 Aug; 4(8):925-37. PubMed ID: 23919472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design and in vitro performance testing of multiple air classifier technology in a new disposable inhaler concept (Twincer) for high powder doses.
    de Boer AH; Hagedoorn P; Westerman EM; Le Brun PP; Heijerman HG; Frijlink HW
    Eur J Pharm Sci; 2006 Jun; 28(3):171-8. PubMed ID: 16650739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficiency of budesonide delivery via a mesh nebulizer in an in-vitro neonatal ventilator model.
    Esmaeilizand R; Rocha T; Harrison A; Gray S; Fusch G; Dolovich M; Mukerji A
    Pediatr Pulmonol; 2020 Sep; 55(9):2283-2288. PubMed ID: 32519801
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhalation therapy with metered-dose inhalers and dry powder inhalers in mechanically ventilated patients.
    Dhand R
    Respir Care; 2005 Oct; 50(10):1331-4; discussion 1344-5. PubMed ID: 16185369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhalation performance of pollen-shape carrier in dry powder formulation with different drug mixing ratios: comparison with lactose carrier.
    Hassan MS; Lau R
    Int J Pharm; 2010 Feb; 386(1-2):6-14. PubMed ID: 19922775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NanoCluster Itraconazole Formulations Provide a Potential Engineered Drug Particle Approach to Generate Effective Dry Powder Aerosols.
    Pornputtapitak W; El-Gendy N; Berkland C
    J Aerosol Med Pulm Drug Deliv; 2015 Oct; 28(5):341-52. PubMed ID: 25679514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bronchodilation of formoterol administered with budesonide: device and formulation effects.
    Miller CJ; Senn S; Mezzanotte WS
    Contemp Clin Trials; 2008 Mar; 29(2):114-24. PubMed ID: 17625985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improving aerosol drug delivery during invasive mechanical ventilation with redesigned components.
    Longest PW; Azimi M; Golshahi L; Hindle M
    Respir Care; 2014 May; 59(5):686-98. PubMed ID: 24106320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of force control agents in high-dose dry powder inhaler formulations.
    Begat P; Morton DA; Shur J; Kippax P; Staniforth JN; Price R
    J Pharm Sci; 2009 Aug; 98(8):2770-83. PubMed ID: 19067395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In-vitro intra- and inter-inhaler flow rate-dependent dosage emission from a combination of budesonide and eformoterol in a dry powder inhaler.
    Tarsin W; Assi KH; Chrystyn H
    J Aerosol Med; 2004; 17(1):25-32. PubMed ID: 15120010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The in vitro and in vivo investigation of inhaled migraine therapies using a novel aerosol delivery system consisting of an air pressurized capsule device (APCD) in combination with a pMDI spacer for endotracheal dosing into beagle dogs.
    Sellers S; Horodnik W; House A; Wylie J; Mauser P; Garber N; Pu YE; Berry J; Donovan B
    Drug Dev Ind Pharm; 2015; 41(12):1989-96. PubMed ID: 25986873
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhalation performance of pollen-shape carrier in dry powder formulation: effect of size and surface morphology.
    Hassan MS; Lau R
    Int J Pharm; 2011 Jul; 413(1-2):93-102. PubMed ID: 21540087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Albuterol delivery by 4 different nebulizers placed in 4 different positions in a pediatric ventilator in vitro model.
    Berlinski A; Willis JR
    Respir Care; 2013 Jul; 58(7):1124-33. PubMed ID: 23107173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nebulization of a suspension of budesonide and a solution of terbutaline into a neonatal ventilator circuit.
    Turpeinen M; Nikander K
    Respir Care; 2001 Jan; 46(1):43-8. PubMed ID: 11175237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhaled bronchodilator administration during mechanical ventilation: how to optimize it, and for which clinical benefit?
    Guerin C; Fassier T; Bayle F; Lemasson S; Richard JC
    J Aerosol Med Pulm Drug Deliv; 2008 Mar; 21(1):85-96. PubMed ID: 18518835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug delivery to the lungs from dry powder inhalers.
    Newman SP
    Curr Opin Pulm Med; 2003 Apr; 9 Suppl 1():S17-20. PubMed ID: 12974538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers.
    Zeng XM; MacRitchie HB; Marriott C; Martin GP
    Int J Pharm; 2007 Mar; 333(1-2):45-55. PubMed ID: 17064863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Special problems in aerosol delivery: artificial airways.
    Dhand R
    Respir Care; 2000 Jun; 45(6):636-45. PubMed ID: 10894456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhaled bronchodilator administration during mechanical ventilation.
    Duarte AG
    Respir Care; 2004 Jun; 49(6):623-34. PubMed ID: 15165297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sustained mechanical and clinical functionality of the flexhaler dry powder inhaler.
    Lööf T; Elfman P; Ström P; Törngren A; Borgström L
    J Aerosol Med Pulm Drug Deliv; 2008 Dec; 21(4):381-8. PubMed ID: 18823260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.